|
Our key speaker line up includes:
Tony Ellery, Managing Director, Ellery Pharma Consulting, Former Global Head LCM in Portfolio Management, Novartis
Kimber Hardy, Head of Valuation and Analysis, Merck Serono
Tim Harris, Director, Respiratory & Immuno-inflammation Portfolio Management, GlaxoSmithKline
Shafique Virani, Global Head CNS Business Development, F. Hoffman La Roche
Sakir Mutevelic, Head of Global Project Management Biopharmaceuticals Hemophilia A/WD, Baxter
Christiano Pereira Silva, Global Product Manager for Pradaxa, Boehringer-Ingelheim
Julie Barrett-Major, Director of Intellectual Property, Norgine
Alan S. Harris, Senior Vice President, Global Projects & Portfolio Management, Ferring Pharmaceuticals
Christine Deuschel, Vice President Portfolio & Project Management, Debiopharm
Anne Lane, Executive Director, University College London Business
Angel Calvo Yague, Healthcare Platform Council Member, Gerson Lehman Group Healthcare & Biomedical Council
Boris Kreye, Lawyer, Bird & Bird
Bruce D Sunstein, Partner, Sunstein Kann Murphy & Timbers LLP
Kerstin Bode-Greuel, Lecturer, University of Essen/PME Institute
Graham Cox, Senior Consultant, IDEA Pharma
Philip Graves, Market Research Consultant, Philip Graves Consultancy
John Ansell, Honorary Consultant, School of Pharmacy and Pharmaceutical Sciences, University of Manchester
|